Cambridge Cognition reported encouraging interim results to June, with revenues up +39% to £3.0m and the Pre-Tax Loss sharply reduced to £0.4m. The company has made strong progress on its commercialisation strategy this year and, having announced £4.9m of contract wins in H1, a major win for a schizophrenia trial has since increased this to £8.4m. Although CV19 led to some contracted clinical trials being delayed in H1, this has been offset by new contract wins and goi
22 Sep 2020
Price Data Interim results update
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Price Data Interim results update
Cambridge Cognition Holdings Plc (COG:LON) | 52.0 0 0.0% | Mkt Cap: 18.3m
- Published:
22 Sep 2020 -
Author:
Thomas Like -
Pages:
15
Cambridge Cognition reported encouraging interim results to June, with revenues up +39% to £3.0m and the Pre-Tax Loss sharply reduced to £0.4m. The company has made strong progress on its commercialisation strategy this year and, having announced £4.9m of contract wins in H1, a major win for a schizophrenia trial has since increased this to £8.4m. Although CV19 led to some contracted clinical trials being delayed in H1, this has been offset by new contract wins and goi